Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • bio_informatics
    Senior Member
    • Nov 2013
    • 182

    #1

    how to select between genemark.hmm and genemarkS

    Dear Group Members,
    I am working on prokaryotic genome to predict genes. Neisseria meningitidis organism.
    Input file is multi contig fasta format.

    output gff3 file format is needed.

    I could come up with 4 Ab initio good tools:
    1 - gilmmer3,
    2 - prodigal
    3 - genemark.hmm
    4 - genemarkS

    Easygenes/Fgenes: I am not sure of these, how good are these.
    However, I need to drop either GenemarkS or GeneMark.hmm.

    I am unable to figure out the criteria.
    GeneMarkS - gives start, stop, gene_name and strand.
    But it is the best for statistical data. Provides option to remove overlap. No sequence in nucleotide or amino acids

    GeneMark.hmm - gives gff outout, cannot remove overlap,
    Gives amino acids & nucleotide sequence.

    Other tools for validation - TriTISA is not working,
    Homology based - genewise, there are bugs in the .c files of it.

    I am confused if I should go for BLAST or BLAT and why.
    Last edited by bio_informatics; 02-06-2014, 11:04 PM.
    Bioinformaticscally calm

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...